Brenntag shares fall as chemicals price pressures hit forecast
Q1 operating EBITA at 260 mln euros, down 24% y/y
Sees guidance at low end of 1.23-1.43 bln euro range
Shares fall by almost 9%
Adds analysts and CEO quote from call in paragraphs 4-7, updates share move
By Marta Frackowiak and Matteo Allievi
May 14 (Reuters) -Brenntag's BNRGn.DE shares dropped sharply on Tuesday after the German chemicals distributor lowered its annual earnings forecast and missed first-quarter estimates due to price pressures and lower-than-expected demand in some areas.
Chemicals firms have cut inventories over the past two years due to weak demand, but some are seeing tentative recovery signs as volumes slowly pick up in the U.S., Europe and China.
Brenntag said that higher volumes were not making up for lower prices, without giving exact figures.
"Finding the right price points at this moment is a little bit tricky as we have not been fully meeting the expectations in Q1," said CEO Christian Kohlpaintner in an analyst call.
But there were "encouraging signs" on price improvements, he said, especially in its warehouse business builders.
Brenntag's finance chief Kristin Neumann said that although demand was picking up in beauty, healthcare and nutrition, the material science sector was slightly slower.
Volume growth was coming from the EMEA and North America regions, while Latin America, which accounts for less than 10% of Brenntag's revenue, was its weakest market, while China was also still not fully back on track, Neumann told reporters.
Barclays analysts said in a note that price normalisation was steeper than expected in the quarter.
Kohlpaintner said in a call the company was seeing increased logistics costs and extended shipping times as a result of a spate of attacks on ships in the Red Sea, but no disruption.
Brenntag's shares were down 8.4% at 1432 GMT, their lowest level since November, after it said it expects 2024 operating earnings before interest, tax and amortisation (EBITA) to be at the lower end of a 1.23 billion to 1.43 billion euro range.
Analysts had forecast operating EBITA of 1.27 billion euros ($1.37 billion) in 2024 in a poll by Vara Research.
Brenntag's said its quarterly operating EBITA fell 24% year-on-year to 259.7 million euros, below the estimate of 279.4 million euros.
It expects the first half to be more challenging than the second, but was "cautiously optimistic" that market conditions will improve during 2024.
Operating EBITA fell by more than 20% in both of Brenntag's divisions, while first-quarter sales fell 12% to 4 billion euros from a year ago, also missing analyst estimates.
JP Morgan analysts said in a note that the lowered guidance implies a substantial earnings rebound in the rest of 2024, to around 320 million euros per quarter.
($1 = 0.9272 euros)
Reporting by Marta Frąckowiak and Matteo Allievi in Gdansk; Editing by Alexander Smith
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
